4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-20-032970
Chief Medical Officer acquired 5,515 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Detke Michael J. · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-27 | Exercise or conversion : show line 1 in the form | +5,515 | $6.91 | $38,109 | 28,261 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-27 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −5,515 | 104,091 | D |
Loading xslF345X03/doc4.xml…